Veterinary Stereotactic Radiosurgery Systems Market Driven by Key Factors from 2026–2035
The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
How Is The Market Size Of The Biobetters Market Expected To Change Between 2026 And 2030?
The veterinary stereotactic radiosurgery system market size has seen substantial expansion in recent years. This market is projected to grow from $3.28 billion in 2025 to $3.69 billion in 2026, achieving a compound annual growth rate (CAGR) of 12.6%. The growth observed in the historic period can be attributed to the rising incidence of cancer in companion animals, advancements in veterinary oncology, the growth of veterinary specialty hospitals, increasing availability of imaging technologies, and the demand for precision radiation therapy.
The veterinary stereotactic radiosurgery system market is projected to experience swift expansion over the coming years. It is anticipated to reach a valuation of $5.9 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.5%. This projected growth can be attributed to several factors, including the advancement of high-precision radiation delivery systems, the incorporation of AI in treatment planning, the expansion of canine and feline oncology initiatives, rising investments in veterinary cancer treatments, and the increasing presence of contract research organizations (CROs) dedicated to supporting animal oncology. Key trends anticipated during this period encompass the growing acceptance of stereotactic radiosurgery within veterinary oncology, the creation of less invasive treatment alternatives, the integration of sophisticated imaging for accurate tumor targeting, the proliferation of specialized veterinary cancer facilities, and an increased understanding of available pet cancer treatment choices.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7805&type=smp
Which Economic Or Industry Drivers Are Impacting The Biobetters Market?
The escalating number of pets is anticipated to fuel the expansion of the veterinary stereotactic radiosurgery system market in the future. The term ‘pet population’ signifies the collective count of domesticated creatures like dogs, cats, and various other companions, maintained and cared for by individuals within a particular region or community. This population is increasing as a greater number of households are welcoming animals into their homes for companionship, leading to an elevated count of pets being cared for across communities. These veterinary stereotactic radiosurgery systems offer significant assistance to the pet population by delivering accurate, non-surgical treatment for growths and other severe ailments, thereby enhancing recovery results and overall well-being. For illustration, data from July 2025, released by the World Animal Foundation (WAF), a US-based organization focused on animal welfare, indicates that pet ownership has reached 71% of U.S. households, an increase from 66% recorded between 2023–2024. Consequently, the expansion in the pet population is a key factor propelling the development of the veterinary stereotactic radiosurgery system market.
How Is The Biobetters Market Structured Across Different Segments?
The veterinary stereotactic radiosurgery system market covered in this report is segmented –
1) By Product: Microsurgical Instrumentation, Imaging And Visualization Systems, Radiation Therapy Systems And Software
2) By Modality: Gamma Knife, Linear Accelerator, Particle Beam Radiation Therapy, Cyber Knife
3) By Application: Canine, Feline, Other Applications
4) By End User: Hospitals, Contract Research Organizations (CROs), Other End Users
Subsegments:
1) By Microsurgical Instrumentation: Stereotactic Frames, Navigation Systems, Targeting Devices
2) By Imaging And Visualization Systems: Imaging Systems, Surgical Microscopes
3) By Radiation Therapy Systems And Software: Treatment Planning Software, Radiation Delivery Systems, Positioning Accessories Or Immobilization Devices
Which Trends Are Shaping The Future Of The Veterinary Stereotactic Radiosurgery System Market?
Leading firms within the veterinary stereotactic radiosurgery system sector are prioritizing technological innovations, specifically AI-powered image-guided treatment delivery systems, to secure a market edge. These AI-enhanced platforms are comprehensive digital solutions that merge artificial intelligence with advanced imaging and robotic control mechanisms. Their purpose is to meticulously plan, prescribe, and accurately administer stereotactic radiation therapies as part of a prescribed delivery service, thereby boosting treatment precision, cutting down on procedure durations, and improving the efficiency of clinical operations. An example of this trend occurred in September 2024 when Bluepearl Veterinary Partners LLC, a veterinary care provider based in the US, launched the CyberKnife System specifically for animal treatment. This system incorporates a robotic linear accelerator that can emit high-energy photon beams from various directions, offers real-time imaging guidance to limit exposure to healthy tissues, and provides sub-millimeter targeting accuracy for intricate tumors. While this implementation broadens availability of sophisticated oncology services for animals and enhances specialized clinical capacities, it necessitates substantial investment in staff training and supporting infrastructure.
Which Major Players Dominate The Biobetters Market?
Major companies operating in the veterinary stereotactic radiosurgery system market are PetCure Oncology, Elekta AB, Accuray Incorporated, Varian Medical Systems Inc., ZAP Surgical Systems Inc., Brainlab AG, Best Medical International Inc., Mevion Medical Systems Inc., Vision RT Limited, ViewRay Inc., Xstrahl Ltd., Avante Health Solutions, Medtronic plc, RaySearch Laboratories, Best Theratronics Ltd., MASEP Medical Science Technology Development Co Ltd, RefleXion Medical Inc., CIVCO Radiotherapy, Xcision Medical Systems, GammaVet, RadVet, ALCEN, Isoray Inc., PTW Freiburg GmbH, Ion Beam Applications SA, Nanovi Radiotherapy AS
Read the full veterinary stereotactic radiosurgery system market report here:
What Are The Top-Performing Regions Within The Biobetters Market?
North America was the largest region in the veterinary stereotactic radiosurgery system market in 2025. The regions covered in the veterinary stereotactic radiosurgery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Biobetters Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7805&type=smp
Browse Through More Reports Similar to the Global Veterinary Stereotactic Radiosurgery System Market 2026, By The Business Research Company
Radiosurgery And Radiotherapy Robotics Global Market Report 2026
Veterinary Surgical Instruments Global Market Report 2026
Stereotactic Surgery Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/stereotactic-surgery-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
